Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Tarec Christoffer El-Galaly; Lasse Hjort Jakobsen; Martin Hutchings; Peter de Nully Brown; Herman Nilsson-Ehle; Erzsébet Szekely; Karen Juul Mylam; Viktoria Hjalmar; Hans Erik Johnsen; Martin Bøgsted; Mats Jerkeman

doi:10.1200/JCO.2015.62.0229

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, Martin Hutchings, Peter de Nully Brown, Herman Nilsson-Ehle, Erzsébet Szekely, Karen Juul Mylam, Viktoria Hjalmar, Hans Erik Johnsen, Martin Bøgsted, Mats Jerkeman

Research output: Contribution to journal › Article › peer-review

Abstract

Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.

Original language	English
Pages (from-to)	3993-3998
Journal	Journal of Clinical Oncology
Volume	33
Issue number	34
DOIs	https://doi.org/10.1200/JCO.2015.62.0229
Publication status	Published - 2015

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2015.62.0229

http://www.ncbi.nlm.nih.gov/pubmed/26438115?dopt=Abstract

Cite this

El-Galaly, T. C., Jakobsen, L. H., Hutchings, M., de Nully Brown, P., Nilsson-Ehle, H., Szekely, E., Mylam, K. J., Hjalmar, V., Johnsen, H. E., Bøgsted, M., & Jerkeman, M. (2015). Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study. Journal of Clinical Oncology, 33(34), 3993-3998. https://doi.org/10.1200/JCO.2015.62.0229

@article{d54e49892a324af69999d0e48a14e865,

title = "Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.",

abstract = "Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.",

author = "El-Galaly, {Tarec Christoffer} and Jakobsen, {Lasse Hjort} and Martin Hutchings and {de Nully Brown}, Peter and Herman Nilsson-Ehle and Erzs{\'e}bet Szekely and Mylam, {Karen Juul} and Viktoria Hjalmar and Johnsen, {Hans Erik} and Martin B{\o}gsted and Mats Jerkeman",

year = "2015",

doi = "10.1200/JCO.2015.62.0229",

language = "English",

volume = "33",

pages = "3993--3998",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "Lippincott Williams & Wilkins",

number = "34",

}

El-Galaly, TC, Jakobsen, LH, Hutchings, M, de Nully Brown, P, Nilsson-Ehle, H, Szekely, E, Mylam, KJ, Hjalmar, V, Johnsen, HE, Bøgsted, M & Jerkeman, M 2015, 'Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.', Journal of Clinical Oncology, vol. 33, no. 34, pp. 3993-3998. https://doi.org/10.1200/JCO.2015.62.0229

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study. / El-Galaly, Tarec Christoffer; Jakobsen, Lasse Hjort; Hutchings, Martin et al.
In: Journal of Clinical Oncology, Vol. 33, No. 34, 2015, p. 3993-3998.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

AU - El-Galaly, Tarec Christoffer

AU - Jakobsen, Lasse Hjort

AU - Hutchings, Martin

AU - de Nully Brown, Peter

AU - Nilsson-Ehle, Herman

AU - Szekely, Erzsébet

AU - Mylam, Karen Juul

AU - Hjalmar, Viktoria

AU - Johnsen, Hans Erik

AU - Bøgsted, Martin

AU - Jerkeman, Mats

PY - 2015

Y1 - 2015

N2 - Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.

AB - Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.

U2 - 10.1200/JCO.2015.62.0229

DO - 10.1200/JCO.2015.62.0229

M3 - Article

C2 - 26438115

SN - 1527-7755

VL - 33

SP - 3993

EP - 3998

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 34

ER -

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this